Treatment with the investigational therapeutic rusfertide has proven to be a potential treatment option for patients with ...

Being a cancer survivor for nine and a half years has taught me to live in the moment, to make those moments count.

The U.S. FDA has approved treatment with Ibtrozi for patients with locally advanced or metastatic ROS1-positive non-small ...

FDA granted priority review to Zepzelca plus Tecentriq for first-line maintenance in extensive-stage small cell lung cancer.

Two people connect by sharing their experiences about taking care of their spouses who died from cancer, and the realization ...

Patients can prepare for self-advocacy by bringing personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner.